Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
Isabelle Mahé, Head of Internal Medicine, Louis Mourier Hospital, APHP, Paris Cité University, shared on LinkedIn:
”The Proposals from the French multidisciplinary INNOVTE CAT Working Group for the management of cancer-associated thromboembolism have been published in ACVD.
Executive summary.”
Venous thromboembolism (VTE) is a frequent and serious complication in cancer patients, with rising incidence but declining mortality, leading to a growing population requiring long-term management of cancer-associated thrombosis (CAT).
Because CAT care is increasingly complex, a multidisciplinary French working group reviewed challenges in real-world practice—including care pathways, home management, treatment decisions, and management of special populations such as the elderly, patients with renal impairment, brain tumors, thrombocytopenia, or central venous catheters.
The group highlights significant gaps in evidence, particularly for high-risk subgroups and recurrent VTE, and proposes practical guidance to improve coordination and clinical decision-making across specialties.
Read the full article here.
Article: The management of cancer-associated thromboembolism: Proposals from the French multidisciplinary INNOVTE CAT Working Group
Authors: Isabelle Mahé, Ygal Benhamou, Asmahane Benmaziane, Laurent Bertoletti, Virginie Bichon, Coralie Bozec, Ariel Cohen, Francis Couturaud, Philippe Debourdeau, Pascale Dielenseger, Éric Douriez, Antoine Elias, Olivier Espitia, Corinne Frère, Yoann Gaboreau, Pascale Gendron, Philippe Girard, Olivier Hanon, Ahmed Idbaih, Silvy Laporte, Didier Mayeur, Farès Moustafa, Gilles Pernod, Pierre-Marie Roy, Marie-Eve Rouge Bugat, Jeannot Schmidt, Florian Scotte, Marie-Antoinette Sevestre, Patrick Mismetti, Olivier Sanchez
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis